What if a treatment could prevent tissue damage from becoming a serious osteoarthritis case months, or even decades later? This is the challenge being tackled by researchers at Drexel’s School of Biomedical Engineering, Science and Health Systems, in conjunction with researchers at Villanova University, University of Delaware and Tulane University, recently published in ACS Nano.
Thirty years ago, George H.W. Bush was the U.S. President, and the United States was in a two-month war: Operation Desert Storm. A total of 154 U.S. service members died and approximately 250,000 returned home suffering from a host of chronic symptoms, ranging from memory deficits, mood disorders, gastrointestinal problems, to headaches and sleep disorders. These health problems, caused by exposure during battle to chemicals such as pesticides, nerve agents and certain prophylactic drugs, continue to plague these veterans — a diagnosis known as Gulf War Illness.
Deaths skyrocketing from the nation’s opioid crisis overshadows another growing nightmare for communities and families across the United States: the long-term health effects of nonfatal opioid overdoses. In a new review paper in International Journal […]
Herbert B. Allen, a professor and chair emeritus in the College of Medicine, offers a bold challenge to colleagues: consider whether penicillin could help prevent Alzheimer’s, and when combined with a disperser, whether penicillin may slow progression of the disease — or maybe even stop it altogether.
Reflecting on how Philadelphians reacted when the pandemic first hit may help us learn to be better prepared for changes in this pandemic, as well as other health crises down the road.
More than 150 million Americans – 46% of the country – has received at least one dose of a COVID-19 vaccine, and 36% of the country’s population is fully vaccinated. Despite very rare side effects, public health officials consider vaccines to be effective at preventing severe illness and be the ticket to something resembling pre-pandemic life.haryha
Many scientists believe that SARS-CoV-2, the virus responsible for COVID-19, will become “endemic.” It will seasonally circulate in a similar fashion to the other common respiratory viruses, such as those that cause the common cold or flu. If this bears out, there will not be a true end to the pandemic (with accompanying ticker tape parade down Broad Street), but a gradual transition, to an illness that we will have to live with.
Transplant programs and potential donors have faced hard questions about risk tolerance due to the COVID-19 pandemic. These are some of the questions that researchers from Drexel University’s College of Medicine and Dornsife School of Public Health posed to prior and prospective organ donors across the United States.
If you’re frequently trying to make sense of the number of local and national COVID-19 cases and deaths from the CDC’s tracker or other places, but are unsure what it all means, you’re not alone.
Three recent papers from researchers in Drexel University’s Dornsife School of Public Health, discuss continued inequalities and growing challenges faced by many immigrants in the U.S. They also offer opportunities for a creative refocus of present efforts to help close these gaps.